Tema Oncology ETF (CANC) Chart & Stock Price History $38.12 0.00 (0.00%) As of 05/22/2026 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Stock Price Performance The Tema Oncology ETF (CANC) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 57.13%, with a year-to-date return of 9.79%. In the past month, the fund has decreased 0.63%, reflecting recent market activity. As of the latest close, Tema Oncology ETF traded at $38.12 with a market cap of $178.78 million and volume of 9,192 shares. Receive CANC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.17%1 Month Performance-0.63%3 Month Performance+1.09%Year-To-Date Performance+9.79%1 Year Performance+57.13% CANC Stock Chart for Monday, May, 25, 2026 CANC Chart by TradingView Tema Oncology ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/25/2026$38.12$38.12$38.40$38.069,192 shs$178.78 million05/22/2026$38.17$38.12-0.13%$38.40$38.069,192 shs$178.78 million05/21/2026$37.68$38.17+1.30%$38.40$37.289,179 shs$179.02 million05/20/2026$36.73$37.68+2.59%$37.81$36.6610,386 shs$176.72 million05/19/2026$36.58$36.73+0.41%$37.02$36.107,088 shs$172.26 million05/18/2026$37.09$36.58-1.38%$37.21$36.358,129 shs$171.56 million05/15/2026$37.97$37.09-2.32%$37.50$36.8513,496 shs$173.95 million05/14/2026$38.02$37.97-0.13%$38.20$37.656,836 shs$178.08 million05/13/2026$37.65$38.02+0.98%$38.30$37.2321,422 shs$178.31 million05/12/2026$37.33$37.65+0.86%$37.79$37.286,730 shs$176.58 million Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 05/11/2026$37.36$37.33-0.08%$38.27$37.1411,974 shs$175.08 million05/08/2026$37.39$37.36-0.08%$37.63$37.1810,018 shs$175.22 million05/07/2026$38.39$37.39-2.60%$38.43$37.2711,089 shs$175.36 million05/06/2026$37.89$38.39+1.32%$38.65$38.029,986 shs$180.05 million05/05/2026N/A$37.89$38.18$37.5427,368 shs$177.70 million04/30/2026$36.58$37.51+2.54%$37.59$36.8621,039 shs$175.92 million04/29/2026$37.27$36.58-1.85%$37.23$36.5425,200 shs$171.56 million04/28/2026$37.78$37.27-1.35%$37.68$37.1149,863 shs$174.80 million04/27/2026$38.36$37.78-1.51%$38.83$37.7837,094 shs$177.19 million04/24/2026$38.38$38.36-0.05%$38.53$37.819,632 shs$179.91 million Related Companies SDG Stock Price Chart COPJ Stock Price Chart FINX Stock Price Chart NZAC Stock Price Chart KOID Stock Price Chart ELFY Stock Price Chart CHGX Stock Price Chart EMXF Stock Price Chart QQMG Stock Price Chart FBOT Stock Price Chart Receive CANC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CANC) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
